ArticleOncotarget2017

Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer.

Anderly C Chüeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.